Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study

DOI record: { "DOI": "10.1016/j.biopha.2022.112729", "ISSN": [ "0753-3322" ], "URL": "http://dx.doi.org/10.1016/j.biopha.2022.112729", "alternative-id": [ "S0753332222001172" ], "article-number": "112729", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study" }, { "label": "Journal Title", "name": "journaltitle", "value": "Biomedicine & Pharmacotherapy" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.biopha.2022.112729" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2022 Published by Elsevier Masson SAS." } ], "author": [ { "affiliation": [], "family": "Khorshiddoust", "given": "Reza Ramazani", "sequence": "first" }, { "affiliation": [], "family": "Khorshiddoust", "given": "Saleh Ramazani", "sequence": "additional" }, { "affiliation": [], "family": "Hosseinabadi", "given": "Tahereh", "sequence": "additional" }, { "affiliation": [], "family": "Mottaghitalab", "given": "Faezeh", "sequence": "additional" }, { "affiliation": [], "family": "Mokhtari", "given": "Farzad", "sequence": "additional" }, { "affiliation": [], "family": "Azadinia", "given": "Fatemeh", "sequence": "additional" }, { "affiliation": [], "family": "Mozdarani", "given": "Hossein", "sequence": "additional" }, { "affiliation": [], "family": "Shabani", "given": "Mohammad", "sequence": "additional" }, { "affiliation": [], "family": "Emadi-Kouchak", "given": "Hamid", "sequence": "additional" }, { "affiliation": [], "family": "Taheri", "given": "Bahram", "sequence": "additional" }, { "affiliation": [], "family": "Khani-Juyabad", "given": "Fatemeh", "sequence": "additional" }, { "affiliation": [], "family": "Kashani", "given": "Mina Amjadi", "sequence": "additional" }, { "affiliation": [], "family": "Sadoughi", "given": "Arezoo", "sequence": "additional" }, { "affiliation": [], "family": "Zamanizadeh", "given": "Sorour", "sequence": "additional" }, { "affiliation": [], "family": "Maddah", "given": "Hadyeh", "sequence": "additional" }, { "affiliation": [], "family": "Aminzadeh", "given": "Maedeh", "sequence": "additional" }, { "affiliation": [], "family": "Khanaki", "given": "Maryam", "sequence": "additional" }, { "affiliation": [], "family": "Saremi", "given": "Sabereh", "sequence": "additional" }, { "affiliation": [], "family": "Rad", "given": "Anahita Pashaee", "sequence": "additional" }, { "affiliation": [], "family": "Fatehi", "given": "Ali", "sequence": "additional" }, { "affiliation": [], "family": "Rad", "given": "Melika Ghaznavi", "sequence": "additional" }, { "affiliation": [], "family": "Haftbaradaran", "given": "Masoud", "sequence": "additional" }, { "affiliation": [], "family": "Khosroshahi", "given": "Mehran", "sequence": "additional" }, { "affiliation": [], "family": "Sadeghi", "given": "Mahtab", "sequence": "additional" }, { "affiliation": [], "family": "Aminnayeri", "given": "Majid", "sequence": "additional" }, { "affiliation": [], "family": "Jafari", "given": "Sirous", "sequence": "additional" }, { "affiliation": [], "family": "Ghiasvand", "given": "Fereshteh", "sequence": "additional" }, { "affiliation": [], "family": "Seifi", "given": "Arash", "sequence": "additional" }, { "affiliation": [], "family": "Ghaderkhani", "given": "Sara", "sequence": "additional" }, { "affiliation": [], "family": "Manshadi", "given": "Seyed Ali Dehghan", "sequence": "additional" }, { "affiliation": [], "family": "Salehi", "given": "Mohammadreza", "sequence": "additional" }, { "affiliation": [], "family": "Abbasian", "given": "Ladan", "sequence": "additional" }, { "affiliation": [], "family": "Hasannezhad", "given": "Malihe", "sequence": "additional" }, { "affiliation": [], "family": "Meidani", "given": "Mohsen", "sequence": "additional" }, { "affiliation": [], "family": "Hajiabdolbaghi", "given": "Mahboubeh", "sequence": "additional" }, { "affiliation": [], "family": "Ahmadinejad", "given": "Zahra", "sequence": "additional" }, { "affiliation": [], "family": "Parash", "given": "Masoud", "sequence": "additional" }, { "affiliation": [], "family": "Sedighi", "given": "Zahra", "sequence": "additional" }, { "affiliation": [], "family": "Mohammadian", "given": "Abdorreza", "sequence": "additional" } ], "container-title": [ "Biomedicine & Pharmacotherapy" ], "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "em-consulte.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2022, 2, 17 ] ], "date-time": "2022-02-17T04:00:38Z", "timestamp": 1645070438000 }, "deposited": { "date-parts": [ [ 2022, 3, 18 ] ], "date-time": "2022-03-18T02:11:40Z", "timestamp": 1647569500000 }, "indexed": { "date-parts": [ [ 2022, 3, 18 ] ], "date-time": "2022-03-18T11:12:56Z", "timestamp": 1647601976456 }, "is-referenced-by-count": 0, "issn-type": [ { "type": "print", "value": "0753-3322" } ], "issued": { "date-parts": [ [ 2022, 5 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 5, 1 ] ], "date-time": "2022-05-01T00:00:00Z", "timestamp": 1651363200000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 2, 16 ] ], "date-time": "2022-02-16T00:00:00Z", "timestamp": 1644969600000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0753332222001172?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0753332222001172?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "112729", "prefix": "10.1016", "published": { "date-parts": [ [ 2022, 5 ] ] }, "published-print": { "date-parts": [ [ 2022, 5 ] ] }, "publisher": "Elsevier BV", "reference": [ { "key": "10.1016/j.biopha.2022.112729_bib1", "unstructured": "World Health Organization Dashboard; Available from: 〈https://www.covid19.who.int〉." }, { "article-title": "Post-acute neurological consequences of COVID-19: an unequal burden", "author": "Nolen", "first-page": "1", "journal-title": "Nat. Med.", "key": "10.1016/j.biopha.2022.112729_bib2", "year": "2022" }, { "DOI": "10.1016/j.biopha.2021.111352", "article-title": "SARS-CoV-2: from the pathogenesis to potential anti-viral treatments", "author": "Zarandi", "doi-asserted-by": "crossref", "journal-title": "Biomed. Pharmacother.", "key": "10.1016/j.biopha.2022.112729_bib3", "year": "2021" }, { "DOI": "10.1016/j.biopha.2021.112015", "article-title": "COVID-19 challenges and its therapeutics", "author": "Rehman", "doi-asserted-by": "crossref", "journal-title": "Biomed. Pharmacother.", "key": "10.1016/j.biopha.2022.112729_bib4", "volume": "142", "year": "2021" }, { "DOI": "10.1038/s41579-020-00459-7", "article-title": "Characteristics of SARS-CoV-2 and COVID-19", "author": "Hu", "doi-asserted-by": "crossref", "first-page": "141", "issue": "3", "journal-title": "Nat. Rev. Microbiol.", "key": "10.1016/j.biopha.2022.112729_bib5", "volume": "19", "year": "2021" }, { "author": "Wang", "first-page": "1", "key": "10.1016/j.biopha.2022.112729_bib6", "series-title": "Will the COVID-19 Pandemic End with the Delta and Omicron Variants?", "year": "2022" }, { "DOI": "10.1016/S0140-6736(22)00100-3", "article-title": "COVID-19 will continue but the end of the pandemic is near", "author": "Murray", "doi-asserted-by": "crossref", "journal-title": "Lancet", "key": "10.1016/j.biopha.2022.112729_bib7", "year": "2022" }, { "DOI": "10.3390/v12040372", "article-title": "Virology, epidemiology, pathogenesis, and control of COVID-19", "author": "Jin", "doi-asserted-by": "crossref", "first-page": "372", "issue": "4", "journal-title": "Viruses", "key": "10.1016/j.biopha.2022.112729_bib8", "volume": "12", "year": "2020" }, { "DOI": "10.1001/jama.2020.12839", "article-title": "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review", "author": "Wiersinga", "doi-asserted-by": "crossref", "first-page": "782", "issue": "8", "journal-title": "JAMA", "key": "10.1016/j.biopha.2022.112729_bib9", "volume": "324", "year": "2020" }, { "DOI": "10.1021/acs.molpharmaceut.0c00608", "article-title": "COVID-19 transmission, current treatment, and future therapeutic strategies", "author": "Salian", "doi-asserted-by": "crossref", "first-page": "754", "issue": "3", "journal-title": "Mol. Pharm.", "key": "10.1016/j.biopha.2022.112729_bib10", "volume": "18", "year": "2021" }, { "DOI": "10.1186/s13104-019-4343-8", "article-title": "Human protein-coding genes and gene feature statistics in 2019", "author": "Piovesan", "doi-asserted-by": "crossref", "first-page": "1", "issue": "1", "journal-title": "BMC Res. Notes", "key": "10.1016/j.biopha.2022.112729_bib11", "volume": "12", "year": "2019" }, { "DOI": "10.1038/s41586-020-2286-9", "article-title": "A SARS-CoV-2 protein interaction map reveals targets for drug repurposing", "author": "Gordon", "doi-asserted-by": "crossref", "first-page": "459", "issue": "7816", "journal-title": "Nature", "key": "10.1016/j.biopha.2022.112729_bib12", "volume": "583", "year": "2020" }, { "DOI": "10.1007/s11192-021-03989-w", "article-title": "Research on Covid-19: a disruptive phenomenon for bibliometrics", "author": "Fassin", "doi-asserted-by": "crossref", "first-page": "5305", "issue": "6", "journal-title": "Scientometrics", "key": "10.1016/j.biopha.2022.112729_bib13", "volume": "126", "year": "2021" }, { "DOI": "10.3389/fpubh.2020.00383", "article-title": "COVID-19: a multidisciplinary review", "author": "Chams", "doi-asserted-by": "crossref", "first-page": "383", "journal-title": "Front. Public Health", "key": "10.1016/j.biopha.2022.112729_bib14", "volume": "8", "year": "2020" }, { "DOI": "10.7150/ijms.47836", "article-title": "Advances and challenges in the prevention and treatment of COVID-19", "author": "Han", "doi-asserted-by": "crossref", "first-page": "1803", "issue": "12", "journal-title": "Int. J. Med. Sci.", "key": "10.1016/j.biopha.2022.112729_bib15", "volume": "17", "year": "2020" }, { "DOI": "10.1016/j.biopha.2021.111518", "article-title": "Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy", "author": "Mirtaleb", "doi-asserted-by": "crossref", "journal-title": "Biomed. Pharmacother.", "key": "10.1016/j.biopha.2022.112729_bib16", "year": "2021" }, { "DOI": "10.1007/s12088-020-00919-x", "article-title": "Recent clinical trials on natural products and traditional Chinese medicine combating the COVID-19", "author": "Nile", "doi-asserted-by": "crossref", "first-page": "10", "issue": "1", "journal-title": "Indian J. Microbiol.", "key": "10.1016/j.biopha.2022.112729_bib17", "volume": "61", "year": "2021" }, { "DOI": "10.1007/s10238-020-00671-y", "article-title": "Emerging treatment strategies for COVID-19 infection", "author": "Gavriatopoulou", "doi-asserted-by": "crossref", "first-page": "167", "issue": "2", "journal-title": "Clin. Exp. Med.", "key": "10.1016/j.biopha.2022.112729_bib18", "volume": "21", "year": "2021" }, { "DOI": "10.1016/S2214-109X(20)30365-X", "article-title": "Clinical trials of disease stages in COVID 19: complicated and often misinterpreted", "author": "Park", "doi-asserted-by": "crossref", "issue": "10", "journal-title": "Lancet Glob. Health", "key": "10.1016/j.biopha.2022.112729_bib19", "volume": "8", "year": "2020" }, { "DOI": "10.1007/s40121-020-00349-8", "article-title": "Early treatment of COVID-19 disease: a missed opportunity", "author": "Forrest", "doi-asserted-by": "crossref", "first-page": "715", "issue": "4", "journal-title": "Infect. Dis. Ther.", "key": "10.1016/j.biopha.2022.112729_bib20", "volume": "9", "year": "2020" }, { "author": "Mesarović", "first-page": "59", "key": "10.1016/j.biopha.2022.112729_bib21", "series-title": "Systems Theory and Biology—View of a Theoretician, in Systems Theory and Biology", "year": "1968" }, { "DOI": "10.1042/EBC20180003", "article-title": "Systems biology primer: the basic methods and approaches", "author": "Tavassoly", "doi-asserted-by": "crossref", "first-page": "487", "issue": "4", "journal-title": "Essays Biochem.", "key": "10.1016/j.biopha.2022.112729_bib22", "volume": "62", "year": "2018" }, { "key": "10.1016/j.biopha.2022.112729_bib23", "unstructured": "R.R.K. Doust, Systems-biology based pharmaceutical composition comprising a mixture of herb extracts as active ingredients, use of said composition as a medicament, particularly in the treatment of human coronavirus infections such as covid-19, M. PHARMA, Editor. 22: Norway." }, { "article-title": "Impurities: guideline for residual solvents Q3C (R5)", "author": "Guideline", "first-page": "1", "journal-title": "Curr. Step", "key": "10.1016/j.biopha.2022.112729_bib24", "volume": "4", "year": "2005" }, { "DOI": "10.1016/j.jobb.2020.12.001", "article-title": "Heat inactivation of the severe acute respiratory syndrome coronavirus 2", "author": "Batéjat", "doi-asserted-by": "crossref", "first-page": "1", "issue": "1", "journal-title": "J. Biosaf. Biosecurity", "key": "10.1016/j.biopha.2022.112729_bib25", "volume": "3", "year": "2021" }, { "DOI": "10.1111/j.1537-2995.2006.00976.x", "article-title": "Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products", "author": "Darnell", "doi-asserted-by": "crossref", "first-page": "1770", "issue": "10", "journal-title": "Transfusion", "key": "10.1016/j.biopha.2022.112729_bib26", "volume": "46", "year": "2006" }, { "article-title": "Effective heat inactivation of SARS-CoV-2", "author": "Wang", "journal-title": "MedRxiv", "key": "10.1016/j.biopha.2022.112729_bib27", "year": "2020" }, { "DOI": "10.1186/1471-2288-4-26", "article-title": "Random allocation software for parallel group randomized trials", "author": "Saghaei", "doi-asserted-by": "crossref", "first-page": "1", "issue": "1", "journal-title": "BMC Med. Res. Methodol.", "key": "10.1016/j.biopha.2022.112729_bib28", "volume": "4", "year": "2004" }, { "DOI": "10.1016/j.biopha.2022.112658", "article-title": "Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights", "author": "Ali", "doi-asserted-by": "crossref", "journal-title": "Biomed. Pharmacother.", "key": "10.1016/j.biopha.2022.112729_bib29", "volume": "147", "year": "2022" }, { "DOI": "10.1556/1886.2021.00022", "article-title": "Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants", "author": "Goc", "doi-asserted-by": "crossref", "journal-title": "Eur. J. Microbiol. Immunol.", "key": "10.1016/j.biopha.2022.112729_bib30", "year": "2022" }, { "DOI": "10.1080/07391102.2022.2027271", "article-title": "Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease", "author": "Garg", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "J. Biomol. Struct. Dyn.", "key": "10.1016/j.biopha.2022.112729_bib31", "year": "2022" }, { "DOI": "10.1016/j.jiph.2020.06.016", "article-title": "In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing", "author": "Kumar", "doi-asserted-by": "crossref", "first-page": "1210", "issue": "9", "journal-title": "J. Infect. Public Health", "key": "10.1016/j.biopha.2022.112729_bib32", "volume": "13", "year": "2020" }, { "DOI": "10.1155/2020/6307457", "article-title": "Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: a molecular docking study", "author": "Tallei", "doi-asserted-by": "crossref", "journal-title": "Scientifica", "key": "10.1016/j.biopha.2022.112729_bib33", "volume": "2020", "year": "2020" }, { "article-title": "In silico screening of some naturally occurring bioactive compounds predicts potential inhibitors against SARS-CoV-2 (COVID-19) protease", "author": "Mishra", "journal-title": "arXiv preprint arXiv:2004.01634", "key": "10.1016/j.biopha.2022.112729_bib34", "year": "2020" }, { "DOI": "10.1016/j.tim.2020.12.007", "article-title": "Dysregulation of cell signaling by SARS-CoV-2", "author": "Suryawanshi", "doi-asserted-by": "crossref", "first-page": "224", "issue": "3", "journal-title": "Trends Microbiol.", "key": "10.1016/j.biopha.2022.112729_bib35", "volume": "29", "year": "2021" } ], "reference-count": 35, "references-count": 35, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0753332222001172" } }, "score": 1, "short-container-title": [ "Biomedicine & Pharmacotherapy" ], "short-title": [], "source": "Crossref", "subject": [ "Pharmacology", "General Medicine" ], "subtitle": [], "title": [ "Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study" ], "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "149" }